PTPRC and common variable immunodeficiency: Our data add to previous reports (33, 34) favoring a role for this SNV in a polygenic scenario for CVID, although the frequency of (heterozygous) carriers of C77G in CD45 was not increased in a large CVID cohort (33) and different clinical phenotypes have been associated with C77G in CD45.